AMD1通过精氨酸-eIF5A低化-TCF4轴促进乳腺癌的攻击性
Ruocen Liao1,2, Xingyu Chen3,2, Qianhua Cao3,2
1Department of Breast Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, 310058, Hangzhou, China.
过度表达S-adenosylmethionine脱碳酶 (AMD1) 预酶,通过提高精氨酸水平,驱动出具有攻击性的基本性乳腺癌 (BLBC). 这一途径涉及eIF5A低化和TCF4激活,为BLBC提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 基底类乳腺癌 (BLBC) 具有高度攻击性,治疗选择有限.
- 驱动BLBC攻击性的分子机制尚未完全理解.
- 在BLBC中,S-adenosylmethionine脱碳酶前酶 (AMD1) 特别过度表达.
研究的目的:
- 调查AMD1在促进BLBC攻击性的作用.
- 阐明AMD1有助于BLBC进展的分子机制.
主要方法:
- 评估了AMD1对细胞增殖,迁移和入侵的影响.
- 使用高性能液态染色学测量精素水平.
- 分析了AMD1促进体甲基化及其与Sox10.0的关系.
- 利用体外和体内模型来评估AMD1对瘤生长的影响.
主要成果:
- 在BLBC中,AMD1表达显著升高,由基因放大,低甲基化和Sox10活性驱动.
- 过度表达AMD1会增加精氨酸,导致eIF5A的低和TCF4的翻译激活.
- 由AMD1调节的聚胺代谢系统促进瘤细胞的增殖和生长.
- 升高的AMD1与高度,转移和患者生存率差的相关性.
结论:
- 通过AMD1介导的精子胺-eIF5A化-TCF4轴对BLBC的攻击性至关重要.
- AMD1 作为乳腺癌患者潜在的预后指标.
- 这一途径代表了BLBC治疗的有前途的治疗标.
更多相关视频
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
相关概念视频
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
TGF - β Signaling Pathway
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
PI3K/mTOR/AKT Signaling Pathway
